The global patient monitoring devices market size is expected to reach USD 118.21 billion by 2033, registering a CAGR of 10.21% from 2025 to 2033, according to a new report by Grand View Research, Inc ...
The CGM market is expected to experience double-digit percentage growth over the next five years, reaching nearly $29 billion ...
Samples collected for fine grinding testwork, mine design & costing ADELAIDE, AU / ACCESS Newswire / November 3, 2025 / ...
Researchers at the Indian Institute of Technology–Madras have developed a patented, minimally invasive continuous glucose ...
An international team of researchers, with the Australian trial led by Distinguished Professor David Simmons from the University's School of Medicine ...
Generated Q3 revenue of $8.1 million, representing year-over-year growth of 90%Achieved a 160% increase in U.S. new patient ...
The CGM market is an exciting, fast-growing, multibillion-dollar medtech sector, according to our new Medtech Market ...
7d
Dr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB)
Dr. Weber is currently an Assistant Professor at the Johns Hopkins School of Medicine. He previously served as a Medical Officer and Clinical Reviewer at The US Food and Drug Administration (FDA) and ...
Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.
13 analysts have expressed a variety of opinions on DexCom (NASDAQ:DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their ...
The Dexcom G7 Continuous Glucose Monitoring (CGM) System, shown here with an iPhone and an Apple Watch. This story was originally published on MedTech Dive. To receive daily news and insights, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback